- Home
- STTK vs KTCC Comparison
STTK vs KTCC Comparison
Compare STTK & KTCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- KTCC
- Stock Information
- Founded
- STTK 2016
- KTCC 1969
- Country
- STTK United States
- KTCC United States
- Employees
- STTK N/A
- KTCC N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- KTCC Electrical Products
- Sector
- STTK Health Care
- KTCC Technology
- Exchange
- STTK Nasdaq
- KTCC Nasdaq
- Market Cap
- STTK 56.8M
- KTCC 61.1M
- IPO Year
- STTK 2020
- KTCC N/A
- Fundamental
- Price
- STTK $1.11
- KTCC $3.95
- Analyst Decision
- STTK Hold
- KTCC
- Analyst Count
- STTK 3
- KTCC 0
- Target Price
- STTK $2.00
- KTCC N/A
- AVG Volume (30 Days)
- STTK 172.1K
- KTCC 43.0K
- Earning Date
- STTK 02-27-2025
- KTCC 02-04-2025
- Dividend Yield
- STTK N/A
- KTCC N/A
- EPS Growth
- STTK N/A
- KTCC N/A
- EPS
- STTK N/A
- KTCC N/A
- Revenue
- STTK $6,435,000.00
- KTCC $548,388,000.00
- Revenue This Year
- STTK $313.04
- KTCC N/A
- Revenue Next Year
- STTK N/A
- KTCC N/A
- P/E Ratio
- STTK N/A
- KTCC N/A
- Revenue Growth
- STTK 382.75
- KTCC N/A
- 52 Week Low
- STTK $0.94
- KTCC $3.60
- 52 Week High
- STTK $11.76
- KTCC $6.14
- Technical
- Relative Strength Index (RSI)
- STTK 44.36
- KTCC 35.16
- Support Level
- STTK $1.13
- KTCC $3.69
- Resistance Level
- STTK $1.22
- KTCC $4.30
- Average True Range (ATR)
- STTK 0.11
- KTCC 0.21
- MACD
- STTK -0.01
- KTCC 0.03
- Stochastic Oscillator
- STTK 15.15
- KTCC 33.33
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.